Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Available × Paraganglioma × Endocrine × Clear all

Status

Recruiting 25 Completed 19 Unknown 13 Terminated 8 Active not recruiting 7 Withdrawn 4 Enrolling by invitation 3 No longer available 2 Approved for marketing 2 Not yet recruiting 1 Available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Endocrine 1 CNS 1

Conditions

Pheochromocytoma 2 Neuroblastoma 2 Insulinoma 2 Hypoglycemia 2 Hyperinsulinism 2 Recurrence 1 Paraganglioma 1 Neuroendocrine Tumors 1 Neuroectodermal Tumors, Primitive 1 Neoplasms 1 Liposarcoma 1 Fibrosarcoma 1 Congenital Hyperinsulinism 1 Beckwith-Wiedemann Syndrome 1 Adenoma, Islet Cell 1

Interventions

3-Iodobenzylguanidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01590680 2023-02-28

Expanded Access Protocol Using 131I-MIBG

Jubilant DraxImage Inc.

Neuroblastoma, Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡